Clinical trial
Adoptive Cellular Therapy and Radiation Therapy After Surgery in Treating Patients With Esophageal Cancer
NCT01691664 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Adoptive Cellular Therapy and Radiation Therapy After Surgery in Treating Patients With Esophageal Cancer
- Lead sponsor
- Capital Medical University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- September 30, 2012
- Completion date
- June 30, 2022
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
esophageal cancer